MétaCan
Menu
← Back to cohort
Record W2564114794 · doi:10.1182/blood.v118.21.546.546

Conservative Peri-Procedural Anticoagulation Management in Patients with Venous Thromboembolic Disease Results in a Low Proportion of Thrombosis and Bleeding

2011· article· en· W2564114794 on OpenAlexaff
Leslie Skeith, Jay Taylor, Alejandro Lazo‐Langner, Michael J. Kovacs

Bibliographic record

VenueBlood · 2011
Typearticle
Languageen
FieldMedicine
TopicVenous Thromboembolism Diagnosis and Management
Canadian institutionsVictoria HospitalLondon Health Sciences CentreWestern University
Fundersnot available
KeywordsMedicineWarfarinThrombosisCompression stockingsSurgeryLow molecular weight heparinAmbulatoryVenous thrombosisCohortRetrospective cohort studyVenous thromboembolismPulmonary embolismHeparinFondaparinuxInternal medicineAtrial fibrillation

Abstract

fetched live from OpenAlex

Abstract Abstract 546 The optimal strategy for peri-procedural warfarin management in patients with venous thromboembolic disease (VTE) is unknown because most studies to date have included small proportions of VTE patients. Guidelines are largely based on expert opinion and recommend low-molecular-weight heparin (LMWH) bridging in patients at high or moderate risk for VTE. LMWH bridging may be associated with an increased bleeding risk, which if occurs, would result in temporary cessation of anticoagulation (AC) potentially leading to a paradoxical increased thrombotic risk. We conducted a single-center retrospective cohort study to examine the effectiveness of conservative peri-procedural AC management in VTE (DVT or PE) patients. We included all patients from our institution's thrombosis unit between 1993 and 2011 who required peri-procedural AC management for planned procedures. The thrombosis unit has, on average, 800 patients on chronic AC for VTE. Patients were excluded if they had other indications for AC, had an acute VTE <90 days before the procedure, or had no follow-up after the procedure. Our centre uses a conservative bridging strategy in these patients consisting of holding warfarin 5 days before the procedure without administering LMWH. Postoperatively all patients resume warfarin as soon as they can swallow. For ambulatory procedures no LMWH is given after the procedure, whereas patients undergoing in-hospital procedures are usually given prophylactic LMWH starting the morning after surgery until discharge or when the INR is therapeutic, whichever occurs first. The primary outcome was incidence of VTE within 90 days of the procedure. Secondary outcomes were 90-day incidence of major and total bleeding and all-cause mortality. Confidence intervals for proportions were calculated using the Wilson's score method. Groups were compared using χ2 or Fisher's exact tests. Survival analysis was done using the Kaplan-Meier method. Two-sided p values ≤0.05 were considered statistically significant. During the study period there were 634 procedures in 416 patients (47.4% males). The mean age was 64.9 years (SD 15.8) and 79.1% of patients had idiopathic VTE. There were 156 procedures (24.6%) completed in-hospital. Pre- and post-procedure bridging was used in 15 (2.4%) and 153 (24.1%) procedures, respectively. The 90-day cumulative incidence of VTE was 0.63% (95% CI 0.25–1.61). The VTE events were 4 DVTs (postoperative day 3, 29, 41, 43) with no associated mortality. The 90-day cumulative incidence of major and total bleeding events was 1.58% (95% CI 0.86–2.88) and 3.47% (95% CI 2.30–5.20), respectively. All-cause mortality rate was 0.63% (95% CI 0.25–1.61); one patient died from a myocardial infarction 3 days after an abdominal aortic aneurysm repair, a second died from an ischemic stroke the morning of a colonoscopy and 2 patients had non-VTE related deaths. The effects of type of procedure and use of bridging on outcomes are shown in Table 1. The use of pre- or post-procedure bridging was not associated with VTE or bleeding. There were significantly more total bleeding events with inpatient procedures. There was a significant correlation between bleeding and VTE events: 13.6% of patients with any bleeding and 30% with major bleeding developed a VTE complication compared with 0.2% of those without bleeding. Spearman's correlation coefficients were 0.311 and 0.470, respectively (p<0.001). Two postoperative DVTs (50%) developed after warfarin was held for an extended period of time (1 major bleed, 1 neurosurgical complication). Conservative peri-procedural AC management in VTE patients on warfarin for at least 3 months results in a low risk of thrombotic and bleeding events. A randomized controlled trial in chronically anticoagulated VTE patients is needed to provide definitive conclusions but a conservative approach appears promising.Effect of Type of Procedure and Bridging on OutcomeOutcomeVTE N (%)No (N=630)Yes (N=4)PInpatient procedure154 (24.4%)2 (50%)0.255Pre-procedure bridging15 (2.4)0 (0)1Post-procedure bridging151 (24)2 (50)0.247Total Bleeding N (%)No (N=612)Yes (N=22)Inpatient procedure146 (23.9)10 (45.5)0.039Pre-procedure bridging15 (2.5)0 (0)1Post-procedure bridging147 (24)6 (27.3)0.800Major bleeding N (%)No (N=624)Yes (N=10)Inpatient procedure153 (24.5)3 (30)0.714Pre-procedure bridging15 (2.4)0 (0)1Post-procedure bridging151 (24.2)2 (20)1 Disclosures: Lazo-Langner: Pfizer Inc.: Honoraria; Leo Pharma: Honoraria.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.009
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.009

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.009
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.026
GPT teacher head0.252
Teacher spread0.226 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2011
Admission routes1
Has abstractyes

Explore more

Same venueBlood→Same topicVenous Thromboembolism Diagnosis and Management→French-language works237,207→